SavedAdd your journal

Journals / Turkish Thoracic Journal / 2020 / Cilt: 21 - Sayı: 4

Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base

Abdullah SAYINER
Pages
283–284
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SAYINER, A. (2020). Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base. Turkish Thoracic Journal, Cilt: 21 - Sayı: 4, 283–284. https://ajindex.com/articles/418108

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. World Health Organization. COVID-19 Situation Dashboard. Available from: URL. https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd 2
  2. TC Sağlık Bakanlığı, Halk Sağlığı Genel Müdürlüğü. Available from: URL:
  3. World Health Organization. COVID-19 Situation Report. Available from: URL:
  4. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COVID-19 (SARS-CoV2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması) 25 Mart 2020. www.hsgm.saglik.gov.tr 5. Agrawal S, Gupta N, Goel AD. Evidence based treatment of SARS-CoV2 - A narrative review. Turk Thorac J 2020;21(3):221-2. [Crossref] 6. Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020
  5. Yao X, Ye F, Zhang M, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020. [Crossref] 8. Wu X, Cai Y, Huang X, et al. Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg Infect Dis 2020. [Crossref]